Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016
(1995; 156 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoACKNOWLEDGMENTS
Ver el documentoPREFACE
Ver el documentoEXECUTIVE SUMMARY
Abrir esta carpeta y ver su contenido1. INTRODUCTION
Ver el documento2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT
Ver el documento3. ACTIVITIES UNDERTAKEN: Preparations and Method of Work
Abrir esta carpeta y ver su contenido4. ANALYSIS OF RESULTS FROM IMPORTING COUNTRIES
Abrir esta carpeta y ver su contenido5. ANALYSIS OF RESULTS FROM EXPORTING COUNTRIES
Ver el documento6. ANALYSIS OF RESULTS FROM INTERNATIONAL SUPPLY AGENCIES
Abrir esta carpeta y ver su contenido7. SUMMARY ANALYSIS
Ver el documento8. CONCLUSIONS
Ver el documentoANNEX 1: Resolution adopted by the Twenty-second World Health Assembly
Ver el documentoANNEX 2 (a): Resolution Adopted by the Twenty-Eighth World Health Assembly
Ver el documentoANNEX 2 (b): Certificate of Pharmaceutical Product(S)1
Ver el documentoANNEX 3 (a): Resolution adopted by the Forty-first World Health Assembly
Ver el documentoANNEX 3 (b): Certificate of Pharmaceutical Product(s)1 (Proposed Layout)
Ver el documentoANNEX 4 (a): Proposed Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
Ver el documentoANNEX 4 (b): Certificate of a Pharmaceutical Product
Ver el documentoANNEX 4 (c): Statement of Licensing Status of Pharmaceutical Product(s) Model Statement of Licensing Status of Pharmaceutical Product(s)
Ver el documentoANNEX 4 (d): Manufacturer’s/Official Batch Certificate of a Pharmaceutical Product
Ver el documentoANNEX 5: Protocol for the Assessment of the Use of the WHO Certification Scheme by Importing Country
Ver el documentoANNEX 6: List of Participants in the Study
Ver el documentoANNEX 7: Protocol for the Assessment of the Use of the WHO Certification Scheme by Exporting Country
Ver el documentoANNEX 8: Protocol for the Assessment of the Use of the WHO Certification Scheme in an International Supply Organization
Ver el documentoANNEX 9: Study Instrument for Assessment of the WHO Certification Scheme by Importing Country
Abrir esta carpeta y ver su contenidoANNEX 10: Summaries of Mission Reports on the Assessment of the Use of the WHO Certification Scheme
Ver el documentoBACK COVER
 

Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016

(study carried out from April 1993 to February 1994 in 15 importing countries, two exporting countries and two international low-cost essential drugs supply agencies)

Action Programme on Essential Drugs
World Health Organization

Geneva, January 1995

Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developed countries. The DAP research series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. The Action Programme has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by the Programme to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the DAP research series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.

© World Health Organization 1994

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO). The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019